Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Wednesday 01 February, 2012

GlaxoSmithKline PLC

Total Voting Rights

RNS Number : 6133W
GlaxoSmithKline PLC
01 February 2012









Total Voting Rights and Capital


In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc ("the Company") hereby notifies the market of the following:


The Company's issued share capital as at 31 January 2012 consisted of 5,552,781,871 Ordinary shares of 25p each, of which 501,157,927 Ordinary shares are held in Treasury.


Therefore, the total number of voting rights in the Company is 5,051,623,944. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.




V A Whyte

Company Secretary


1 February 2012



This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t